ストックスクリーナーアプリを入手
11.25
6.84%
0.72
アフターアワーズ：
11.25
前日終値:
$10.53
開ける：
$10.61
24時間の取引高:
477.49K
Relative Volume:
7.06
時価総額：
$165.64M
収益：
$166.88M
当期純損益:
$-74.18M
株価収益率:
-2.2189
EPS:
-5.07
ネットキャッシュフロー:
$1.14M
1週間 パフォーマンス:
+1.17%
1か月 パフォーマンス:
-1.75%
6か月 パフォーマンス:
-30.60%
1年 パフォーマンス:
-56.78%
1日の値動き範囲:
$10.48
$11.46
1週間の範囲:
$10.48
$11.46
52週間の値動き範囲:
$10.47
$29.11
Anika Therapeutics Inc Stock (ANIK) Company Profile
名前
Anika Therapeutics Inc
セクター
電話
(781) 457-9000
住所
32 WIGGINS AVENUE, BEDFORD, MA
ANIK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
11.25 | 165.64M | 166.88M | -74.18M | 1.14M | -5.07 |
|
RGC
Regencell Bioscience Holdings Ltd
|
10.36 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
159.08 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.26 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.42 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.05 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-17 | 開始されました | B. Riley Securities | Buy |
| 2024-11-01 | 繰り返されました | Barrington Research | Outperform |
| 2023-08-14 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | 再開されました | Stephens | Equal-Weight |
| 2022-03-09 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | 開始されました | Stephens | Overweight |
| 2021-07-16 | 開始されました | UBS | Neutral |
| 2020-12-16 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | アップグレード | Sidoti | Neutral → Buy |
| 2020-01-10 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | 開始されました | BWS Financial | Sell |
| 2019-09-24 | 繰り返されました | Barrington Research | Outperform |
| 2019-09-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | アップグレード | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | ダウングレード | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | ダウングレード | Sidoti | Buy → Neutral |
| 2018-07-27 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | アップグレード | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | 繰り返されました | Barrington Research | Outperform |
| 2016-05-09 | アップグレード | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | 繰り返されました | Barrington Research | Outperform |
すべてを表示
Anika Therapeutics Inc (ANIK) 最新ニュース
Comparing Vivos (OTCMKTS:RDGL) & Anika Therapeutics (NASDAQ:ANIK) - Defense World
Two Sigma Investments LP Cuts Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Bank of America Corp DE Boosts Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Millennium Management LLC Sells 14,006 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Squarepoint Ops LLC Invests $212,000 in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Acquired by Wellington Management Group LLP - Defense World
Mackenzie Financial Corp Invests $231,000 in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Public Employees Retirement System of Ohio Invests $137,000 in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ANIK Stock News - GuruFocus
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Latest: Orthopedics Leader Anika Therapeutics Issues New Employee Stock Options Worth $28,625 - Stock Titan
Kalkine Biggest NASDAQ Companies Including Anika Therapeutics in Biotechnology Sector - Kalkine Media
Two Sigma Advisers LP Sells 12,800 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Ameriprise Financial Inc. Boosts Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Long Term Trading Analysis for (ANIK) - news.stocktradersdaily.com
Jane Street Group LLC Acquires 3,065 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
BNP Paribas Financial Markets Increases Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Deutsche Bank AG Lowers Stock Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Orthopedic Regenerative Medicine Market Is Booming Worldwide | - openPR.com
Anika Therapeutics focuses on Hyalofast and Cingal advancements for 2025 growth - MSN
Anika Therapeutics (ANIK) Sees Target Price Adjustment Amid Futu - GuruFocus
Tower Research Capital LLC TRC Acquires 2,326 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics (NASDAQ:ANIK) Downgraded by StockNews.com to “Hold” - Defense World
Anika Therapeutics (ANIK) Stock Maintains "Outperform" Rating De - GuruFocus
Viscosupplementation Market: Executive Briefing & Strategic - openPR.com
Company News for May 12, 2025 - Zacks Investment Research
Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates - MSN
Wells Fargo & Company MN Boosts Stock Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Investor Network: Anika Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2025 Earnings Call Transcript - Insider Monkey
Anika Therapeutics First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Revenues Working Against Anika Therapeutics, Inc.'s (NASDAQ:ANIK) Share Price - simplywall.st
Anika Therapeutics (ANIK) Faces OEM Challenges Amid Commercial G - GuruFocus
Dimensional Fund Advisors LP Sells 50,011 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika: Q1 Earnings Snapshot - News-Times
Anika Reports First Quarter 2025 Financial Results - GlobeNewswire
Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue ... - Yahoo Finance
Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue Challenges - GuruFocus
Earnings call transcript: Anika Therapeutics Q1 2025 misses forecasts, shares fall - Investing.com Nigeria
Anika Therapeutics Reports Mixed Q1 2025 Results - TipRanks
Anika Therapeutics’ Mixed Earnings Call Reveals Challenges and Growth - TipRanks
Anika Therapeutics Inc Reports Q1 2025 Earnings: EPS of -$0.28 M - GuruFocus
Anika Therapeutics (ANIK) Faces OEM Challenges Amid Commercial Growth - GuruFocus
Anika Therapeutics (ANIK) Reports Revenue Miss, Highlights Strat - GuruFocus
Anika Therapeutics Inc Reports Q1 2025 Earnings: EPS of -$0.28 Misses Estimate, Revenue of $26.2M Below Expectations - GuruFocus
Anika Therapeutics Posts Wider Loss From Cont. Ops. In Q1 - Nasdaq
Anika (ANIK) Revises 2025 Revenue and Adjusted EBITDA Outlook | ANIK Stock News - GuruFocus
Anika Therapeutics Reports 18% Growth in Commercial Channel Revenue for Q1 2025 Despite Overall Revenue Decline - Nasdaq
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Call Transcript - MSN
Barclays PLC Buys 2,093 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Earnings To Watch: Anika Therapeutics Inc (ANIK) Reports Q1 2025 Result - GuruFocus
Anika Therapeutics Inc (ANIK) 財務データ
収益
当期純利益
現金流量
EPS
Anika Therapeutics Inc (ANIK) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Nunes Anne | SVP, Chief Operations Officer |
Mar 17 '25 |
Option Exercise |
0.00 |
3,637 |
0 |
21,722 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 17 '25 |
Option Exercise |
0.00 |
6,448 |
0 |
49,847 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 17 '25 |
Option Exercise |
0.00 |
25,132 |
0 |
209,472 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 11 '25 |
Option Exercise |
0.00 |
2,561 |
0 |
18,837 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 11 '25 |
Option Exercise |
0.00 |
7,663 |
0 |
45,649 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 11 '25 |
Option Exercise |
0.00 |
30,060 |
0 |
197,015 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,296 |
0 |
17,235 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 10 '25 |
Option Exercise |
0.00 |
5,465 |
0 |
39,590 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 10 '25 |
Option Exercise |
0.00 |
20,002 |
0 |
172,826 |
| Nunes Anne | SVP, Chief Operations Officer |
Oct 01 '24 |
Option Exercise |
0.00 |
2,491 |
0 |
14,211 |
2.01%
0.40%
大文字化:
|
ボリューム (24 時間):